BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,674,360 | +35.1% | 77,000 | +51.6% | 0.00% | 0.0% |
| Q1 2023 | $4,940,000 | +56055.5% | 50,800 | -40.2% | 0.00% | 0.0% |
| Q4 2022 | $8,797 | -99.9% | 85,000 | -18.0% | 0.00% | 0.0% |
| Q2 2022 | $8,594,000 | +162.3% | 103,700 | +138.9% | 0.00% | – |
| Q1 2021 | $3,277,000 | -89.4% | 43,400 | -87.7% | 0.00% | -100.0% |
| Q4 2020 | $30,990,000 | +269.0% | 353,400 | +219.8% | 0.01% | +400.0% |
| Q3 2020 | $8,398,000 | +174.5% | 110,500 | +345.6% | 0.00% | 0.0% |
| Q2 2020 | $3,059,000 | -63.8% | 24,800 | -75.2% | 0.00% | -50.0% |
| Q1 2020 | $8,450,000 | +270.1% | 100,000 | +270.4% | 0.00% | – |
| Q4 2019 | $2,283,000 | +82.2% | 27,000 | +91.5% | 0.00% | – |
| Q1 2019 | $1,253,000 | -51.6% | 14,100 | -53.6% | 0.00% | -100.0% |
| Q4 2018 | $2,589,000 | -46.6% | 30,400 | -39.2% | 0.00% | 0.0% |
| Q3 2018 | $4,849,000 | -45.2% | 50,000 | -46.8% | 0.00% | -50.0% |
| Q2 2018 | $8,855,000 | +118.4% | 94,000 | +88.0% | 0.00% | +100.0% |
| Q1 2018 | $4,054,000 | -9.1% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,459,000 | -19.7% | 50,000 | -16.7% | 0.00% | 0.0% |
| Q3 2016 | $5,551,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 240,400 | $19,922,000 | 0.01% |
| SIMPLEX TRADING, LLC | 43,900 | $3,637,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 33,900 | $2,809,000 | 0.00% |
| JPMORGAN CHASE & CO | 103,700 | $8,594,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |